beta-alanine has been researched along with Diffuse Parenchymal Lung Disease in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both early treatment and late treatment with dabigatran etexilate attenuated the development of bleomycin-induced pulmonary fibrosis." | 3.77 | Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. ( Akter, T; Bogatkevich, GS; Ludwicka-Bradley, A; Nietert, PJ; Silver, RM; van Ryn, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogatkevich, GS | 1 |
| Ludwicka-Bradley, A | 1 |
| Nietert, PJ | 1 |
| Akter, T | 1 |
| van Ryn, J | 1 |
| Silver, RM | 1 |
1 other study available for beta-alanine and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Topics: Administration, Oral; Animals; Antithrombins; Benzimidazoles; beta-Alanine; Bleomycin; Dabigatran; D | 2011 |